Market

The Market

The European medical cannabis market is growing steadily. Many EU countries are rethinking their respective cannabis policies and adjusting laws for the distribution of medical cannabis as an alternative medicine. Countries like the Netherlands, Denmark and Portugal position themselves as strong growing regions, whereas other EU countries focus on distribution.

After legalization in March 2017, Germany established itself as one of the world’s largest distribution markets for medical cannabis.

In 2018, 60,000 patients in Germany had received prescription medical cannabis. The number of prescriptions is expected to increase enormously over the next ten years.

The years of dependence on North American suppliers will end with the products manufactured in Europe by the end of 2020.

Based on these market trends, Ilios Santé GmbH has entered into valuable partnerships with European companies in the areas of cultivation, production, refinement, and logistics services for cannabis products – with the primary goal in mind: to improve the lives of patients across Europe.

Der Markt

Der europäische medizinische Cannabis-Markt nimmt stetig zu. Viele EU-Länder überdenken ihre jeweilige Cannabis-Politik und passen Gesetze für das Vertreiben von medizinischem Cannabis als Alternativmedizin an. Länder wie die Niederlande, Dänemark und Portugal positionieren sich als starke Anbauregionen, wohingegen andere EU-Länder den Fokus auf die Distribution setzen. Deutschland etablierte sich nach der Legalisierung im März 2017 zu einem der weltweit größten Absatzmärkte für medizinisches Cannabis.

Projected Market Value

In addition to sales, Ilios Santé GmbH has a strong focus on educating doctors, pharmacists and other industry-specific staff regarding the mode of action and availability of cannabinoid-containing medical products. The goal is to demonstrate the therapeutic benefits of medical cannabis as an alternative medicine and to break the stigma of the industry.